|
|
||||||||
Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark
Although infection with Mycobacterium tuberculosis (M.tb) induces a robust CD8 T cell response, the role of CD8 T cells in the defense against M.tb, and the mechanisms behind the induction of CD8 T cells, is still not clear. TB10.4 is a recently described Ag that is expressed by both bacillus Calmette-Guérin (BCG) and M.tb. In the present study, we describe a novel CD8 T cell epitope in TB10.4, TB10.43-11. We show that TB10.43-11-specific CD8 T cells are induced at the onset of infection and are present throughout the infection in high numbers. TB10.43-11 CD8 T cells were recruited to the site of infection and expressed CD44, TNF-
, and IFN-
. In addition, TB10.43-11 CD8 T cells showed an up-regulation of FasL and LAMP-1/2 (CD107A/B), which correlated with a strong in vivo cytolytic activity. The induction of TB10.43-11-specific CD8 T cells was less pronounced following infection with BCG compared to infection with M.tb. By using a rBCG expressing the genetic region of difference-1 (RD1), we show that the presence of a functional RD1 region increases the induction of TB10.43-11-specific CD8 T cells as well as the bacterial virulence. Finally, as an M.tb variant lacking the genetic region RD1 also induced a significant amount of TB10.43-11-specific CD8 T cells, and exhibited increased virulence compared with BCG, our data suggest that virulence in itself is also involved in generating a robust CD8 T cell response against mycobacterial epitopes, such as TB10.43-11.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was partially supported by Danish Research Agency, Ministry of Science, Technology and Innovation.
2 Address correspondence and reprint requests to Dr. Jes Dietrich, Department of Infectious Disease Immunology, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark. E-mail address: JDI{at}ssi.dk
3 Abbreviations used in this paper: M.tb, Mycobacterium tuberculosis; TB, tuberculosis; BCG, bacillus Calmette-Guérin; MHC-I, MHC class I; MHC-II, MHC class II; RD1, region of difference-1.
This article has been cited by other articles:
![]() |
T. Einarsdottir, E. Lockhart, and J. L. Flynn Cytotoxicity and Secretion of Gamma Interferon Are Carried Out by Distinct CD8 T Cells during Mycobacterium tuberculosis Infection Infect. Immun., October 1, 2009; 77(10): 4621 - 4630. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schiller, H. M. Vordermeier, W. R. Waters, M. Palmer, T. Thacker, A. Whelan, R. Hardegger, B. Marg-Haufe, A. Raeber, and B. Oesch Assessment of Mycobacterium tuberculosis OmpATb as a Novel Antigen for the Diagnosis of Bovine Tuberculosis Clin. Vaccine Immunol., September 1, 2009; 16(9): 1314 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. S. Andersen, I. Rosenkrands, A. W. Olsen, P. Nordly, D. Christensen, R. Lang, C. Kirschning, J. M. Gomes, V. Bhowruth, D. E. Minnikin, et al. Novel Generation Mycobacterial Adjuvant Based on Liposome-Encapsulated Monomycoloyl Glycerol from Mycobacterium bovis Bacillus Calmette-Guerin J. Immunol., August 15, 2009; 183(4): 2294 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Venkataswamy, A. Baena, M. F. Goldberg, G. Bricard, J. S. Im, J. Chan, F. Reddington, G. S. Besra, W. R. Jacobs Jr., and S. A. Porcelli Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin J. Immunol., August 1, 2009; 183(3): 1644 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Ryan, J. K. Nambiar, T. M. Wozniak, B. Roediger, E. Shklovskaya, W. J. Britton, B. Fazekas de St. Groth, and J. A. Triccas Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection J. Immunol., June 1, 2009; 182(11): 7172 - 7177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Woodworth, Y. Wu, and S. M. Behar Mycobacterium tuberculosis-Specific CD8+ T Cells Require Perforin to Kill Target Cells and Provide Protection In Vivo J. Immunol., December 15, 2008; 181(12): 8595 - 8603. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |